Skip to main content

biomarker Archives

Analysis reveals macrophages associated with kidney cancer recurrence

May. 24, 2021—A white blood cell, the TREM2/APOE/C1Q-positive macrophage, has been identified as a potential biomarker to predict recurrence of the most common type of kidney cancer and as a possible target for drug development.

Read more


Imaging “biomarker” for Alzheimer’s disease progression

Nov. 16, 2020—Changes in connectivity in the brain’s white matter may be a novel neuroimaging biomarker for assessing Alzheimer’s disease progression.

Read more


New predictors of prostate cancer risk

Sep. 17, 2020—An international group of researchers including Vanderbilt epidemiologists has identified new DNA methylation biomarkers associated with prostate cancer risk.

Read more


New study examines Alzheimer’s disease images and molecular biomarkers

May. 7, 2020—Alzheimer’s disease (AD) involves distinctive wasting away of certain brain regions, such that medical imaging of these regions can distinguish the disease from other subtypes of dementia.

Read more


Potential prostate cancer biomarkers

Sep. 19, 2019—An analysis of more than 140,000 people of European ancestry has identified blood protein biomarkers associated with prostate cancer risk.

Read more


Cardiac dysfunction in DMD

Mar. 28, 2019—The protein MMP7 is elevated in blood from patients with Duchenne muscular dystrophy who have cardiac dysfunction, suggesting that it may be a biomarker for heart disease severity.

Read more


Team’s study reveals hidden lives of medical biomarkers

Oct. 11, 2018—What do medical biomarkers do on evenings and weekends, when they might be considered off the clock?

Read more


Pregnancy-related heart disorder clues

Jun. 3, 2016—Vanderbilt researchers have identified biomarkers that could be useful for evaluating and treating pregnancy-related heart failure.

Read more


IOM study calls for better evidence for biomarker tests

Mar. 10, 2016—Biomarker tests that help determine which patients may benefit from molecularly targeted therapies need better evidence and oversight to improve their effectiveness and availability, according to a study by the Institute of Medicine (IOM) of the National Academies of Sciences, Engineering, and Medicine.

Read more


Platelet protein modification

Jan. 13, 2016—Vanderbilt investigators have identified a new biomarker to assess platelet function.

Read more


Biomarker for intestinal tumors

Oct. 21, 2015—A new marker could be useful for diagnosing and treating neuroendocrine tumors of the small intestines.

Read more


Skin biopsy to diagnose depression?

Aug. 29, 2014—It may be possible to use skin cells as biomarkers to diagnose and manage depression.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more